Alivus Life Sciences
add_icon

Alivus Life Sciences

1,369.00
-29.70
(-2.12%)
Market Cap
16,803.03 Cr
PE Ratio
28.48
Volume
54,800.00
Day High - Low
1,416.60 - 1,356.30
52W High-Low
1,418.00 - 819.00
ann
There are 2 new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
16,803.03 Cr
EPS
45.99
PE Ratio
28.48
PB Ratio
5.15
Book Value
271.41
EBITDA
771.62
Dividend Yield
0.36 %
Industry
Healthcare
Return on Equity
17.24
Debt to Equity
0.02
Analyst Rating and Forecast
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Alivus Life Sciences to acquire 76% stake in IQGen-X Pharma1 day ago
Alivus Life Sciences board approves acquisition of a 76% stake in IQGen-X Pharma for ₹9.12 crore, marking a strategic move in the pharmaceutical sector.
neutral
Alivus Life Sciences Limited has scheduled a series of one-on-one investor and analyst meetings for August 18 and 19, 2026. The engagements will take place in both virtual and in-person formats across Mumbai.
positive
Alivus Life Sciences Limited submitted its Business Responsibility & Sustainability Report for FY26, highlighting a 54.4% export contribution and voluntary limited assurance by British Standards Institution on core KPIs.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,900.00
#1 4,55,873.64
37.16
#1 61,673.90
12.69
#1 11,565
26.53
42.22
8,560.00
2,27,241.10
78.05
11,067.00
13.95
2,568
65.50
72.51
5,013.00
1,90,678.41
87.77
13,886.20
20.34
2,138
3.28
57.42
1,422.00
1,14,875.60
34.47
29,044.60
2.24
3,870
-39.18
41.47
1,104.50
1,11,138.54
24.26
27,657.90
17.64
5,026
-34.90
43.98
2,225.00
1,01,734.24
#1 18.33
29,038.90
#1 26.75
5,356
16.00
31.49
2,394.00
98,871.24
47.74
14,636.40
14.85
1,938
29.13
40.92
1,170.00
97,656.28
30.95
35,058.60
3.90
4,158
-69.10
41.01
1,801.80
97,271.36
89.91
6,867.80
22.01
890
#1 123.93
62.14
1,624.50
93,470.14
25.64
34,145.20
5.56
3,503
25.21
54.91
Growth Rate
Revenue Growth
5.39 %
Net Income Growth
16.85 %
Cash Flow Change
44.41 %
ROE
-14.61 %
ROCE
-14.94 %
EBITDA Margin (Avg.)
-0.27 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
0
887
1,549
1,886
2,138
2,190
2,295
2,421
2,552
2,664
Expenses
0
639
1,065
1,294
1,507
1,519
1,609
1,704
1,780
1,779
EBITDA
0
248
484
592
631
671
686
717
772
885
Operating Profit %
-5 %
28 %
31 %
31 %
29 %
30 %
30 %
29 %
30 %
31 %
Depreciation
0
19
29
33
38
42
54
61
75
79
Interest
0
1
34
88
28
1
2
2
5
5
Profit Before Tax
0
228
421
471
565
629
631
654
751
801
Tax
0
33
108
119
146
162
160
169
184
195
Net Profit
-0
196
313
352
419
467
471
486
567
603
EPS in ₹
-7.89
24.64
29.04
32.61
35.63
38.11
38.43
39.63
45.99
49.10

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
0
1,475
1,726
1,997
2,471
2,702
2,850
3,411
3,983
Fixed Assets
0
456
546
573
595
781
805
955
1,321
Current Assets
0
931
1,160
1,399
1,765
1,850
1,916
2,335
2,649
Capital Work in Progress
0
80
11
14
92
62
106
102
273
Investments
0
0
0
0
0
0
0
478
692
Other Assets
0
939
1,169
1,410
1,784
1,860
1,939
1,877
0
Total Equity & Liabilities
0
1,475
1,726
1,997
2,471
2,702
2,850
3,411
3,983
Current Liabilities
2
1,380
1,308
1,221
384
497
439
470
508
Non Current Liabilities
0
7
16
23
33
67
79
124
143
Total Equity
-1
88
402
753
2,054
2,138
2,332
2,817
3,332
Reserve & Surplus
-1
86
400
751
2,030
2,114
2,308
2,793
3,308
Share Capital
0
2
2
2
25
25
25
25
25

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
0
2
8
106
397
-228
18
-230
-69
Investing Activities
0
-9
-51
-69
-122
-147
-117
-616
-570
Operating Activities
-1
10
195
388
598
306
414
392
565
Financing Activities
1
1
-137
-214
-79
-388
-279
-6
-64

Share Holding

% Holding
Apr 2021
Aug 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
100.00 %
82.84 %
82.84 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
75.00 %
75.00 %
74.99 %
74.94 %
74.91 %
74.91 %
74.87 %
74.87 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
4.38 %
0.00 %
5.01 %
4.82 %
7.85 %
6.74 %
6.57 %
6.42 %
6.84 %
5.09 %
5.29 %
5.54 %
DIIs
0.00 %
1.34 %
0.30 %
0.32 %
0.50 %
0.71 %
0.79 %
0.09 %
0.00 %
0.58 %
0.64 %
0.59 %
1.40 %
1.57 %
4.16 %
4.86 %
5.19 %
5.61 %
5.47 %
7.12 %
7.28 %
7.18 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
7.99 %
7.97 %
7.72 %
7.80 %
8.14 %
9.14 %
9.77 %
10.87 %
10.02 %
9.20 %
9.20 %
9.09 %
9.13 %
10.63 %
10.99 %
10.50 %
10.34 %
10.14 %
10.21 %
9.87 %
10.05 %
Others
0.00 %
7.83 %
8.89 %
9.11 %
8.86 %
8.31 %
7.21 %
7.29 %
6.28 %
6.55 %
2.92 %
7.36 %
1.64 %
1.64 %
2.36 %
2.41 %
2.74 %
2.69 %
2.64 %
2.67 %
2.69 %
2.36 %
No of Share Holders
7
3,73,362
2,80,300
2,53,726
2,38,578
2,33,538
2,32,203
2,25,730
2,22,866
2,08,267
1,98,764
1,85,531
1,56,183
1,49,396
1,43,960
1,46,840
1,41,977
1,38,500
1,35,643
1,32,748
1,27,969
1,25,559

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 21 42 22.5 5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 5.49 5.41 2.08 0.51 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
08 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Sept 2026 1,331.00 1,398.90
01 Sept 2026 DIVIDEND Dividend
₹ 5.00 /share
01 Sept 2026 1,080.80 1,398.90
23 Nov 2021 DIVIDEND Dividend
₹ 10.50 /share
22 Nov 2021 637.10 611.65
17 Sept 2022 DIVIDEND Dividend
₹ 10.50 /share
15 Sept 2022 489.00 418.95
24 Mar 2023 DIVIDEND Dividend
₹ 21.00 /share
24 Mar 2023 382.65 413.10
17 Oct 2023 DIVIDEND Dividend
₹ 22.50 /share
17 Oct 2023 624.60 667.90
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 1,076.05 1,107.00
09 Oct 2024 CHANGE OF NAME Change Of Name
NA
09 Oct 2024 1,203.25 1,203.25
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 1,173.20 1,073.35
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2025 1,065.60 1,122.65
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,118.90 1,180.60
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Aug 2025 1,024.35 1,030.30
01 Sept 2025 DIVIDEND Dividend
₹ 5.00 /share
01 Sept 2025 1,180.60 944.80
08 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Sept 2025 931.75 921.85
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 905.95 905.65
22 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 Jan 2026 878.00 861.30
14 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2026 1,123.45 1,080.80
30 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2026 1,138.40 1,119.70

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release1 day ago
Announcement under Regulation 30 (LODR)-Acquisition1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Business Responsibility and Sustainability Reporting (BRSR)8 days ago
Reg. 34 (1) Annual Report.8 days ago
Notice Of 15Th Annual General Meeting Of The Company For FY 2025-26 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20158 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2026
Intimation Of Record Date For DividendAug 06, 2026
Intimation Of 15Th Annual General Meeting And Record Date.Aug 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 30, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2026
Unaudited Financial Results For The First Quarter Ended June 30 2026.Jul 30, 2026
Board Meeting Outcome for Unaudited Financial Results For The First Quarter Ended June 30 2026Jul 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 23, 2026
Closure of Trading WindowJul 23, 2026
Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026.Jul 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 15, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 14, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 14, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 14, 2026
Board Meeting Outcome for Audited Financial Results And Recommendation Of Final DividendMay 14, 2026
Audited Financial Results For The Quarter And Year Ended March 31 2026May 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2026
Closure of Trading WindowMay 07, 2026
Board Meeting Intimation for Considering And Approving Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2026 And To Consider And Recommend Dividend If Any On Equity Shares For The Year Ended March 31 2026.May 07, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 07, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 06, 2026
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing Regulations)Feb 25, 2026
Announcement Under Regulation 30 - UpdatesFeb 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 30, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 22, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 22, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 22, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Unifi Flexi Cap Fund Direct-Growth
1.02%
2000
-0.02%
1.02%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
-2
0.00%
0.00%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth
1.33%
0
0.00%
-0.21%
Bandhan Large & Mid Cap Fund Direct-Growth
0.47%
0
0.00%
0.09%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Helios Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Helios Small Cap Fund Direct-Growth
0.79%
0
-0.13%
-0.21%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Bandhan Healthcare Fund Direct-Growth
1.17%
0
0.02%
0.08%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.22%
0
0.00%
-0.01%
Nippon India Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Navi Aggressive Hybrid Fund Direct-Growth
0.60%
0
0.00%
-0.51%

Technical Indicators

RSI(14)
Neutral
74.51
ATR(14)
Less Volatile
46.08
STOCH(9,6)
Overbought
83.84
STOCH RSI(14)
Overbought
86.99
MACD(12,26)
Bullish
11.33
ADX(14)
Strong Trend
45.28
UO(9)
Bearish
59.91
ROC(12)
Uptrend But Slowing Down
20.58
WillR(14)
Overbought
-5.88